Lovisa Afzelius

1.0k total citations
21 papers, 763 citations indexed

About

Lovisa Afzelius is a scholar working on Pharmacology, Computational Theory and Mathematics and Molecular Biology. According to data from OpenAlex, Lovisa Afzelius has authored 21 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 13 papers in Computational Theory and Mathematics and 7 papers in Molecular Biology. Recurrent topics in Lovisa Afzelius's work include Pharmacogenetics and Drug Metabolism (15 papers), Computational Drug Discovery Methods (13 papers) and Drug Transport and Resistance Mechanisms (6 papers). Lovisa Afzelius is often cited by papers focused on Pharmacogenetics and Drug Metabolism (15 papers), Computational Drug Discovery Methods (13 papers) and Drug Transport and Resistance Mechanisms (6 papers). Lovisa Afzelius collaborates with scholars based in Sweden, United States and Italy. Lovisa Afzelius's co-authors include Ismael Zamora, Tommy B. Andersson, Gabriele Cruciani, Collen Masimirembwa, Anders Karlén, Janet Hoogstraate, Jenny Johansson, Anna-Karin Sohlenius-Sternbeck, Patrik Lundquist and Denis Projean and has published in prestigious journals such as Bioinformatics, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Lovisa Afzelius

20 papers receiving 739 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lovisa Afzelius Sweden 13 488 360 261 217 173 21 763
Hugues Dolgos Germany 16 392 0.8× 186 0.5× 208 0.8× 227 1.0× 80 0.5× 26 792
Michael Zientek United States 18 671 1.4× 208 0.6× 485 1.9× 310 1.4× 127 0.7× 32 1.1k
Stuart W. Paine United Kingdom 18 306 0.6× 263 0.7× 270 1.0× 237 1.1× 123 0.7× 61 993
Michael Schrag United States 14 423 0.9× 139 0.4× 219 0.8× 270 1.2× 97 0.6× 20 779
Mark C. Wenlock United Kingdom 12 345 0.7× 482 1.3× 410 1.6× 239 1.1× 202 1.2× 21 1.1k
Ken Grime United Kingdom 18 557 1.1× 188 0.5× 271 1.0× 404 1.9× 96 0.6× 36 1.1k
Vikash K. Sinha Belgium 11 520 1.1× 216 0.6× 178 0.7× 338 1.6× 172 1.0× 12 878
Kirk R. Henne United States 18 769 1.6× 246 0.7× 392 1.5× 307 1.4× 121 0.7× 25 1.4k
John R. Soglia United States 16 461 0.9× 161 0.4× 386 1.5× 175 0.8× 191 1.1× 20 956
Hayley S. Brown United Kingdom 12 772 1.6× 194 0.5× 295 1.1× 478 2.2× 103 0.6× 18 1.3k

Countries citing papers authored by Lovisa Afzelius

Since Specialization
Citations

This map shows the geographic impact of Lovisa Afzelius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lovisa Afzelius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lovisa Afzelius more than expected).

Fields of papers citing papers by Lovisa Afzelius

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lovisa Afzelius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lovisa Afzelius. The network helps show where Lovisa Afzelius may publish in the future.

Co-authorship network of co-authors of Lovisa Afzelius

This figure shows the co-authorship network connecting the top 25 collaborators of Lovisa Afzelius. A scholar is included among the top collaborators of Lovisa Afzelius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lovisa Afzelius. Lovisa Afzelius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Tianyun, Lichy Han, Lovisa Afzelius, et al.. (2021). Distinct clinical phenotypes for Crohn’s disease derived from patient surveys. BMC Gastroenterology. 21(1). 160–160. 7 indexed citations
2.
Han, Lichy, et al.. (2018). Mendelian Disease Associations Reveal Novel Insights into Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 24(3). 471–481. 5 indexed citations
3.
Han, Lichy, Mateusz Maciejewski, William Gordon, et al.. (2017). A probabilistic pathway score (PROPS) for classification with applications to inflammatory bowel disease. Bioinformatics. 34(6). 985–993. 24 indexed citations
4.
Varnäs, Katarina, Anders Juréus, Peter Johnström, et al.. (2016). Integrated Strategy for Use of Positron Emission Tomography in Nonhuman Primates to Confirm Multitarget Occupancy of Novel Psychotropic Drugs: An Example with AZD3676. Journal of Pharmacology and Experimental Therapeutics. 358(3). 464–471. 4 indexed citations
5.
Lundquist, Patrik, Gunilla Englund, Jenny Johansson, et al.. (2014). Functional ATP-Binding Cassette Drug Efflux Transporters in Isolated Human and Rat Hepatocytes Significantly Affect Assessment of Drug Disposition. Drug Metabolism and Disposition. 42(3). 448–458. 41 indexed citations
6.
Lundquist, Patrik, Anna-Karin Sohlenius-Sternbeck, Jenny Johansson, et al.. (2014). The Impact of Solute Carrier (SLC) Drug Uptake Transporter Loss in Human and Rat Cryopreserved Hepatocytes on Clearance Predictions. Drug Metabolism and Disposition. 42(3). 469–480. 36 indexed citations
7.
Englund, Gunilla, Patrik Lundquist, Jenny Johansson, et al.. (2014). Cytochrome P450 Inhibitory Properties of Common Efflux Transporter Inhibitors. Drug Metabolism and Disposition. 42(3). 441–447. 35 indexed citations
8.
Lundquist, Patrik, Urban Fagerholm, Jenny Johansson, et al.. (2014). Prediction of In Vivo Rat Biliary Drug Clearance from an In Vitro Hepatocyte Efflux Model. Drug Metabolism and Disposition. 42(3). 459–468. 11 indexed citations
9.
Sohlenius-Sternbeck, Anna-Karin, Chris Jones, Douglas Ferguson, et al.. (2012). Practical use of the regression offset approach for the prediction ofin vivointrinsic clearance from hepatocytes. Xenobiotica. 42(9). 841–853. 75 indexed citations
10.
Sohlenius-Sternbeck, Anna-Karin, Lovisa Afzelius, Peteris Prūsis, et al.. (2010). Evaluation of the human prediction of clearance from hepatocyte and microsome intrinsic clearance for 52 drug compounds. Xenobiotica. 40(9). 637–649. 96 indexed citations
11.
12.
Prūsis, Peteris & Lovisa Afzelius. (2009). Reduced vdW Radius Improves Site of Metabolism Predictions Using X‐Ray Structure of CYP2D6. QSAR & Combinatorial Science. 28(8). 891–894. 2 indexed citations
13.
Afzelius, Lovisa, Catrin Hasselgren Arnby, Anders Broo, et al.. (2007). State-of-the-art Tools for Computational Site of Metabolism Predictions: Comparative Analysis, Mechanistical Insights, and Future Applications. Drug Metabolism Reviews. 39(1). 61–86. 88 indexed citations
14.
Zhou, Diansong, Lovisa Afzelius, Scott Grimm, et al.. (2006). COMPARISON OF METHODS FOR THE PREDICTION OF THE METABOLIC SITES FOR CYP3A4-MEDIATED METABOLIC REACTIONS. Drug Metabolism and Disposition. 34(6). 976–983. 55 indexed citations
15.
Afzelius, Lovisa, Fabien Fontaine, Anders Karlén, et al.. (2004). Virtual receptor site (VRS) derivation for competitive CYP2C9 inhibitors : - a novel approach for structurally diverse compounds..
16.
Afzelius, Lovisa, Florian Raubacher, Anders Karlén, et al.. (2004). STRUCTURAL ANALYSIS OF CYP2C9 AND CYP2C5 AND AN EVALUATION OF COMMONLY USED MOLECULAR MODELING TECHNIQUES. Drug Metabolism and Disposition. 32(11). 1218–1229. 16 indexed citations
17.
Afzelius, Lovisa, Ismael Zamora, Collen Masimirembwa, et al.. (2004). Conformer- and Alignment-Independent Model for Predicting Structurally Diverse Competitive CYP2C9 Inhibitors. Journal of Medicinal Chemistry. 47(4). 907–914. 38 indexed citations
18.
Zamora, Ismael, Lovisa Afzelius, & Gabriele Cruciani. (2003). Predicting Drug Metabolism:  A Site of Metabolism Prediction Tool Applied to the Cytochrome P450 2C9. Journal of Medicinal Chemistry. 46(12). 2313–2324. 101 indexed citations
19.
Afzelius, Lovisa, Collen Masimirembwa, Anders Karlén, Tommy B. Andersson, & Ismael Zamora. (2002). Discriminant and quantitative PLS analysis of competitive CYP2C9 inhibitors versus non-inhibitors using alignment independent GRIND descriptors. Journal of Computer-Aided Molecular Design. 16(7). 443–458. 37 indexed citations
20.
Afzelius, Lovisa, Ismael Zamora, Marianne Ridderström, et al.. (2001). Competitive CYP2C9 Inhibitors: Enzyme Inhibition Studies, Protein Homology Modeling, and Three-Dimensional Quantitative Structure-Activity Relationship Analysis. Molecular Pharmacology. 59(4). 909–919. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hugues Dolgos Breakdown of academic impact, for papers by Michael Zientek Breakdown of academic impact, for papers by Stuart W. Paine Breakdown of academic impact, for papers by Michael Schrag Breakdown of academic impact, for papers by Mark C. Wenlock Breakdown of academic impact, for papers by Ken Grime Breakdown of academic impact, for papers by Vikash K. Sinha Breakdown of academic impact, for papers by Kirk R. Henne Breakdown of academic impact, for papers by John R. Soglia Breakdown of academic impact, for papers by Hayley S. Brown
Rankless by CCL
2026